Research Article
Utility of Bruton’s Tyrosine Kinase Inhibitors in Light Chain Amyloidosis Caused by Lymphoplasmacytic Lymphoma (Waldenström’s Macroglobulinemia)
Figure 1
Change in difference of free light chains before and after BTK inhibitor therapy. dFLC: difference in free light chain and Rx: therapy.